NewOn orderUnited States
Esprit BTK Resorbable Scaffold System
Abbott
Contact for price
Drug-eluting (everolimus), fully bioresorbable scaffold for below-the-knee peripheral artery disease that dissolves after delivering sustained drug therapy and mechanical support, avoiding a permanent metal implant. FDA approved 2024.
- FDA approval year
- 2024
Categories
CardiologyCardiovascular medicineStents
